Truelove Vogue(003041)
Search documents
浙江真爱美家股份有限公司2025年第三季度报告
Shang Hai Zheng Quan Bao· 2025-10-24 18:54
Core Viewpoint - The company, Zhejiang Zhenai Meijia Co., Ltd., has disclosed its third-quarter financial report for 2025, ensuring the accuracy and completeness of the information provided [1][2]. Financial Data Summary - The third-quarter financial report has not been audited [3][6]. - The company does not require retrospective adjustments or restatements of previous accounting data [3]. - There are no non-recurring profit and loss items applicable for the reporting period [3]. Shareholder Information - The total number of common shareholders and the situation of the top ten shareholders have not been disclosed [5]. Board Meeting Details - The fourth board meeting was held on October 24, 2025, with all nine directors participating [6][7]. - The board approved the third-quarter report with unanimous consent [7]. Foreign Exchange Derivative Trading - The company aims to enhance its ability to manage foreign exchange risks through foreign exchange derivative trading [10]. - The trading amount is capped at $8 million, not exceeding 50% of the latest audited net assets [11][12]. - The company plans to use its own funds for these transactions, avoiding the use of raised funds [13]. Risk Management - The company emphasizes a conservative approach to foreign exchange derivative trading, focusing on risk avoidance rather than speculation [15]. - The company will engage only with qualified financial institutions for these transactions [17].
真爱美家:2025年第三季度归属于上市公司股东的净利润同比增长48.93%
Zheng Quan Ri Bao Zhi Sheng· 2025-10-24 15:08
Group 1 - The core viewpoint of the article is that Zhenai Meijia reported a significant increase in both revenue and net profit for the third quarter of 2025, indicating strong financial performance [1] Group 2 - In the third quarter of 2025, the company achieved a revenue of 334,299,469.70 yuan, representing a year-on-year growth of 10.19% [1] - The net profit attributable to shareholders of the listed company was 33,438,381.02 yuan, showing a year-on-year increase of 48.93% [1]
真爱美家(003041.SZ)发布前三季度业绩,归母净利润2.3亿元,同比增长310.28%
智通财经网· 2025-10-24 11:50
Core Insights - The company, Zhenai Meijia, reported a revenue of 724 million yuan for the first three quarters of 2025, representing a year-on-year growth of 16.16% [1] - The net profit attributable to shareholders reached 230 million yuan, showing a significant year-on-year increase of 310.28% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 58.86 million yuan, reflecting a year-on-year growth of 43.37% [1]
真爱美家(003041.SZ):第三季度净利润同比上升48.93%
Ge Long Hui A P P· 2025-10-24 09:44
Core Viewpoint - The company reported a significant increase in both revenue and net profit for the third quarter of 2025, indicating strong financial performance and growth potential [1] Financial Performance - The company's operating revenue reached 334 million yuan, representing a year-on-year increase of 10.19% [1] - The net profit attributable to shareholders was 33.44 million yuan, showing a year-on-year increase of 48.93% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 31.02 million yuan, reflecting a year-on-year increase of 68.38% [1]
真爱美家:10月24日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-10-24 09:16
Group 1 - The core point of the article is that Zhenai Meijia (SZ 003041) held its 15th meeting of the fourth board on October 24, 2025, to review the proposal for the company's Q3 2025 report [1] - For the first half of 2025, Zhenai Meijia's revenue composition is entirely from the textile industry, accounting for 100.0% [1] - As of the report date, Zhenai Meijia has a market capitalization of 4.1 billion yuan [1] Group 2 - The article also highlights that Chinese innovative drugs have generated $80 billion in overseas licensing this year, indicating a hot secondary market in biomedicine, while the primary market is facing fundraising challenges [1]
真爱美家(003041) - 关于继续开展外汇衍生品交易业务的公告
2025-10-24 08:46
证券代码:003041 证券简称:真爱美家 公告编号:2025-032 浙江真爱美家股份有限公司 关于继续开展外汇衍生品交易业务的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示: 交易金额:任一时点交易金额不超过 8,000 万美金,不超过最近一期经审计 净资产的 50%。预计动用的交易保证金和权利金上限(包括为交易而提供的担保 物价值、预计占用的金融机构授信额度、为应急措施所预留的保证金等)不超过 人民币 3,700 万元,不超过公司最近一期经审计净利润的 50%。 2、审议程序:公司于 2025 年 10 月 24 日分别召开了第四届董事会第十五次 会议审议通过了《关于开展外汇衍生品交易业务的议案》。公司审计委员会已审 议通过本议案。本次开展外汇衍生品交易事项属于公司董事会权限内决策事项, 无需提交股东大会审议。 一、开展外汇衍生品业务的情况 1、开展业务的目的 浙江真爱美家股份有限公司(以下简称"公司")境外销售占比较大,业务 结算货币以美元、欧元等外币为主。由于上年度外汇衍生品交易期限即将到期, 为有效规避外汇市场风险,防范汇率大幅 ...
真爱美家(003041) - 2025 Q3 - 季度财报
2025-10-24 08:45
Financial Performance - The company's revenue for Q3 2025 reached ¥334,299,469.70, representing a 10.19% increase year-over-year[4] - Net profit attributable to shareholders for Q3 2025 was ¥33,438,381.02, a significant increase of 48.93% compared to the same period last year[4] - The basic earnings per share for Q3 2025 was ¥0.2322, reflecting a 48.95% increase year-over-year[4] - The company reported a 310.28% increase in net profit attributable to shareholders for the year-to-date, totaling ¥230,318,133.06[4] - Total operating revenue for the current period reached ¥724,163,669.47, an increase of 16.2% compared to ¥623,412,187.33 in the previous period[19] - Operating profit for the current period was ¥261,744,863.59, significantly up from ¥54,234,657.96 in the previous period, marking an increase of 383.5%[20] - Net profit attributable to the parent company was ¥230,318,133.06, compared to ¥56,136,694.45 in the previous period, representing an increase of 310.5%[20] - Basic and diluted earnings per share for the current period were both ¥1.5994, up from ¥0.3898 in the previous period[20] Assets and Liabilities - Total assets at the end of Q3 2025 amounted to ¥2,114,675,676.20, a decrease of 2.45% from the end of the previous year[4] - Total assets as of September 30, 2025, amounted to CNY 2,114,675,676.20, a decrease from CNY 2,167,782,423.08 at the beginning of the period[17] - Current assets totaled CNY 708,182,033.54, up from CNY 677,407,406.40 at the start of the period, indicating a growth of approximately 1.14%[16] - Total liabilities decreased to CNY 651,251,233.52 from CNY 819,476,113.46, a reduction of approximately 20.5%[17] - Non-current assets totaled CNY 1,406,493,642.66, down from CNY 1,490,375,016.68, indicating a decline of approximately 5.62%[17] - The total equity of the company stood at CNY 1,463,424,442.68, reflecting an increase from CNY 1,348,306,309.62, a growth of approximately 8.5%[17] - The company reported a decrease in total current liabilities to CNY 315,480,653.83 from CNY 395,803,563.33, a reduction of about 20.3%[17] Cash Flow - The company's cash flow from operating activities for the year-to-date reached ¥7,559,713.56, an increase of 127.10%[4] - Cash flow from operating activities generated a net amount of ¥7,559,713.56, a recovery from a net outflow of ¥27,892,616.25 in the previous period[21] - Cash inflow from investment activities totaled ¥430,659,559.96, compared to ¥57,381,622.43 in the previous period, indicating a substantial increase[21] - Cash inflows from financing activities totaled $32,694,877.48, compared to $97,164,029.13 in the previous period, indicating a decrease of approximately 66.4%[22] - Cash outflows from financing activities amounted to $249,371,307.49, up from $154,530,264.39, representing an increase of about 61.5%[22] - The net cash flow from financing activities was -$216,676,430.01, a significant decline from -$57,366,235.26, reflecting a worsening cash position[22] - The ending balance of cash and cash equivalents was $50,811,251.53, down from $69,448,846.33, showing a decrease of approximately 26.8%[22] - The company reported a net decrease in cash and cash equivalents of -$141,067,884.62, compared to -$260,780,341.92 in the previous period, indicating an improvement in cash flow management[22] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 8,683[12] Research and Development - The company reported a significant increase in research and development expenses, totaling ¥47,047,369.35, compared to ¥45,235,733.89 in the previous period[19] Audit Status - The third quarter financial report was not audited, which may affect the reliability of the reported figures[23]
真爱美家(003041) - 第四届董事会第十五次会议决议公告
2025-10-24 08:45
证券代码:003041 证券简称:真爱美家 公告编号:2025-030 表决结果:同意 9 票,反对 0 票,弃权 0 票。 审计委员会对此发表了同意意见。 具体内容详见同日刊载于巨潮资讯网(http://www.cninfo.com.cn)上的《2025 年三季度报告》。 2、审议通过《关于开展外汇衍生品交易业务的议案》 浙江真爱美家股份有限公司 第四届董事会第十五次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 一、会议召开情况 浙江真爱美家股份有限公司(以下简称"公司")第四届董事会第十五次会 议于 2025 年 10 月 24 日以现场加通讯表决的方式召开,会议通知已于 2025 年 10 月 18 日以电子邮件的方式送达各位董事。本次会议由公司董事长郑期中召集 并主持,会议应参加表决的董事 9 人,实际参加表决的董事 9 人,公司高级管理 人员列席。本次会议的通知、召集和召开符合《中华人民共和国公司法》及《浙 江真爱美家股份有限公司章程》的有关规定,合法有效。 二、会议审议情况 1、审议通过《关于公司 2025 年三季度报告的议案》 表 ...
真爱美家:第三季度净利润为3343.84万元,同比增长48.93%
Xin Lang Cai Jing· 2025-10-24 08:41
Group 1 - The core viewpoint of the article highlights the financial performance of the company in the third quarter and the first three quarters of the year, showing significant growth in both revenue and net profit [1] Group 2 - In the third quarter, the company's revenue reached 334 million yuan, representing a year-on-year increase of 10.19% [1] - The net profit for the third quarter was approximately 33.44 million yuan, reflecting a year-on-year growth of 48.93% [1] - For the first three quarters, the total revenue amounted to 724 million yuan, which is a year-on-year increase of 16.16% [1] - The net profit for the first three quarters was around 230 million yuan, showing a remarkable year-on-year growth of 310.28% [1]
今日126只个股突破半年线
Zheng Quan Shi Bao Wang· 2025-10-24 06:20
Core Points - The Shanghai Composite Index closed at 3938.98 points, above the six-month moving average, with a gain of 0.42% [1] - A total trading volume of A-shares reached 1,239.319 billion yuan today [1] - 126 A-shares have surpassed the six-month moving average, with notable stocks showing significant deviation rates [1] Summary by Category Stock Performance - The top three stocks with the highest deviation rates from the six-month moving average are: - Xicet Testing (西测测试) with a deviation rate of 13.84% and a daily increase of 15.21% [2] - Anhui Instrument Technology (皖仪科技) with a deviation rate of 9.60% and a daily increase of 12.74% [2] - Aerospace Changfeng (航天长峰) with a deviation rate of 9.37% and a daily increase of 10.01% [2] Trading Metrics - The trading turnover rate for Xicet Testing was 18.16%, while Anhui Instrument Technology had a turnover rate of 3.91% [2] - The latest prices for the top three stocks are: - Xicet Testing at 58.87 yuan [2] - Anhui Instrument Technology at 24.33 yuan [2] - Aerospace Changfeng at 15.17 yuan [2] Additional Stocks - Other notable stocks with significant performance include: - Tongfeng Electronics (铜峰电子) with a deviation rate of 9.10% and a daily increase of 9.95% [2] - Weihong Technology (维宏股份) with a deviation rate of 7.25% and a daily increase of 10.74% [2] - China Satellite Communications (中国卫通) with a deviation rate of 5.82% and a daily increase of 6.02% [2]